Milena Bjelica

Dr. Milena Bjelica

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
OMOlgica Milankov
Olgica Milankov
RJRajko Jovic
Rajko Jovic
RSRadojica Savic
Radojica Savic
Milena BjelicaMilena Bjelica
Milena Bjelica
Introduction. Hairy polyp is a rare malformation which consists of mesodermal and ectodermal elements. It is the most common congenital nasopharyngeal tumour. The clinical symptoms depend on the size and localization of the mass. Early surgical excision results in permanent cure. Case report. The child was born from regularly controlled pregnancy. Prenatally, in the 24th week of gestation, epulis gigantocellularis was suspected, magnetic resonance imaging confirmed existence of protruding mass. Immediately after the birth, a tissue formation connected with the hard palate was observed protruding out of the mouth, as well as split of soft palate and tongue. In the first day of life the child was intubated and a mechanical ventilatory support started. In the fourth day of life, tracheostomy was performed. In the 40th day of life, the tumor mass was entirely excised with the reconstruction of the existing deformity of the mouth. The histopathological analysis confirmed the diagnosis of hairy polyp. In the fifth month of life, a percutaneous endoscopic gastrostomy was placed. At the beginning of the second age, the split of tongue and soft palate was sewn. With the establishment of normal swallowing, decannulation and closing of tracheostomy were performed and then gastrostomy was closed. Conclusion. Although the hairy polyp is a rare tumor, it must be included in the differential diagnosis of pharyngeal mass in the neonatal period. If there are no associated anomalies and if complete surgical resection of the tumor is performed, further course of the treatment will be favourable.

19 December 2025 in Children
Verified
Journal Article
Open access
PDF file
Milena BjelicaMilena Bjelica
Milena Bjelica
GDGordana Vilotijevic Dautovic
Gordana Vilotijevic Dautovic
SSSlobodan Spasojevic
Slobodan Spasojevic
TRTanja Radovanović
Tanja Radovanović
MPMilica Plazačić
Milica Plazačić
Background/Objectives: Respiratory morbidity in preterm infants has been widely studied, with evidence showing that individuals born prematurely experience more frequent respiratory symptoms, airflow obstruction, and radiological lung abnormalities throughout life. Methods: This study included 150 children aged 6 to 11 years, divided into two groups. The preterm group (n = 90) consisted of children born before 32 weeks of gestation, while the control group (n = 60) included term-born children. All participants underwent spirometry and completed a respiratory health questionnaire. Results: A significantly higher proportion of preterm children exhibited respiratory morbidity compared to term-born peers (χ2 = 7.035; p = 0.030). However, no significant differences were found between preterm children with and without bronchopulmonary dysplasia (BPD) defined at day 28 (BPD28) (χ2 = 0.002; p = 0.968) or BPD defined at 36 weeks postmenstrual age (BPD36) (χ2 = 0.029; p = 0.864). Lung function parameters—forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/IVC, maximal expiratory flow at 25%, 50% and 75% of FVC (MEF25, MEF50, and MEF75) were significantly lower in the preterm group (p = 0.004 for FVC and p < 0.001 for all other parameters). No significant differences were observed between BPD and non-BPD subgroups in any lung function parameter. BPD36 was found to be a stronger predictor of respiratory morbidity (OR = 1.214) than BPD28 (OR = 1.093), although neither BPD28 nor BPD36 were statistically significant predictors. Conclusions: This study underscores the long-term respiratory consequences of prematurity and challenges the traditional view of BPD as the primary determinant of poor respiratory outcomes. Our findings suggest that prematurity itself, rather than BPD, may play a more central role.

1 January 2022 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
MPMilica Plazacic
Milica Plazacic
Milena BjelicaMilena Bjelica
Milena Bjelica
GVGordana Vilotijevic-Dautovic
Gordana Vilotijevic-Dautovic
Introduction. Pneumomediastinum is defined as the presence of free air in the mediastinum. Primary, idiopathic, spontaneous pneumomediastinum is very rare and it affects healthy children with no identifiable cause. Secondary pneumomediastinum may be caused by underlying respiratory disorders, iatrogenic causes or trauma. The most common clinical sign of pneumomediastinum is subcutaneous emphysema, and the most common symptoms are acute chest pain and dyspnea. The diagnosis is confirmed by a chest X-ray or chest computed tomography. Pneumomediastinum is rarely associated with pneumothorax, pneumoperitoneum, and pneumorrhachis. Case Report. In this report, we present a case of a spontaneous pneumomediastinum in a child aged 2 years and 6 months. A child was admitted to our hospital due to massive subcutaneous emphysema. On admission, the patient was without a history of chest trauma or any chronic respiratory tract diseases. He had a mild upper respiratory tract infection 6 days before admission. The diagnosis of pneumomediastinum was confirmed by chest X-ray and computed tomography. After conservative treatment, on the eighth day of hospitalization, there was a complete regression of the pneumomediastinum with normalization of the clinical and radiological findings. Conclusion. Spontaneous pneumomediastinum is the most common benign condition that spontaneously regresses after conservative treatment. Life-threatening complications require surgical decompression. The use of antibiotic therapy in the prophylaxis of mediastinitis has not been proven to be useful. Opinions on the routine use of chest computed tomography in patients with spontaneous pneumomediastinum are still not uniform.

1 January 2021 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
Milena BjelicaMilena Bjelica
Milena Bjelica
GVGordana Vilotijevic-Dautovic
Gordana Vilotijevic-Dautovic
ADAndrea Djuretic
Andrea Djuretic
SSSlobodan Spasojevic
Slobodan Spasojevic
Introduction. Multisystem inflammatory syndrome in children (MIS-C) is a post-viral, life-threatening, inflammatory state with multisystem involvement that typically manifests 3-4 weeks after SARS-CoV-2 infection. In this article, we present the first case of MIS-C in the Institute for Child and Youth Health Care of Vojvodina at the beginning of the COVID-19 pandemic. Case outline. A previously 11-years-old healthy girl got sick two days before admission to the hospital with a fever, headache, vomiting, abdominal pain, and fatigue. She was tested positive for COVID-19 by nasopharyngeal swab PCR with positive IgM and IgG antibodies. In the further course the illness presented with prolonged fever, laboratory evidence of inflammation, multiorgan involvement such as respiratory, gastrointestinal, cardiovascular, and dermatologic. Based on Centers for Disease Control and Prevention and World Health Organization criteria the diagnosis of MIS-C was made and IVIG and methylprednisolone were introduced with favorable clinical course. Conclusion. Every prolonged and unusual febrile state, especially if it is accompanied by gastrointestinal symptoms, in a school-age child, should be investigated in the direction of recent COVID-19 infection or exposure. In a case of a positive COVID-19 history or history of exposure, the MIS-C diagnosis should be considered.

1 January 2026 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
GDGordana Vilotijevic Dautovic
Gordana Vilotijevic Dautovic
ZJZorana Jevtic
Zorana Jevtic
Milena BjelicaMilena Bjelica
Milena Bjelica
Introduction/Objective. Asthma is the most common chronic disease in children. Status asthmaticus is a severe exacerbation of asthma that can lead to hypoxemia and respiratory failure. Diagnosing asthma in preschool-aged children is often challenging as wheezing episodes at this age are most often caused by viral infections. The objective was to assess this issue in our population and improve clinical practice for diagnosing and treating status asthmaticus in preschool children. Methods. A retrospective study included 200 children aged up to five years who were hospitalized with status asthmaticus during January 2019 ? December 2023. Data on patients, diagnostic procedures, therapy, and clinical course were analyzed. Results. The largest proportion of patients was aged one year (31.5%), and males predominated (60.5%). The patients were most commonly hospitalized during the fall months, with an average length of hospital stay of 6.4 days. Allergy was confirmed in 50% of the children. Family history of atopy was present in 56% of the children. Previously diagnosed asthma was present in 13.5% of the children. At discharge, asthma preventive therapy was introduced in 91.5% of the children. All the children had a favorable outcome and were discharged from the hospital. Conclusion. Status asthmaticus most commonly occurs in children in the first year of life, often presenting as the initial manifestation of asthma. More than half of the children had a family history of atopy and confirmed allergies. Timely treatment according to current protocols is crucial for a good outcome.

1 January 2023 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
GVGordana Vilotijevic-Dautovic
Gordana Vilotijevic-Dautovic
RJRajko Jovic
Rajko Jovic
NVNada Vuckovic
Nada Vuckovic
Milena BjelicaMilena Bjelica
Milena Bjelica
MPMilica Plazacic
Milica Plazacic
Introduction. Inflammatory myofibroblastic tumors predominantly manifest in the lungs of children and young adults, with tracheal localization being very rare. Genetic alternations involving the anaplastic lymphoma kinase gene are identified in 50 to 70% of cases. A conclusive diagnosis relies on biopsy and histopathological analysis. Surgical resection stands as the primary treatment modality. Case Report. We present a case involving a 3-year-old boy with an inflammatory myofibroblastic tumor who had experienced recurrent wheezing attributed to respiratory infections since the age of eight months. Long-term therapy with budesonide and montelukast was initiated, which effectively managed his wheezing until the age of 3 years. Subsequently, despite ongoing medication, he began experiencing severe bronchial obstructions every month, necessitating repeated hospital admissions. At the age of 3 years and 8 months, he was admitted to our hospital due to persistent wheezing, prompting a bronchoscopy. During the procedure, a tumor-like mass was identified in the lower part of the trachea. Bronchoscopic removal of the tumor was performed, followed by cauterization of the remaining tumor tissue. Histopathological examination confirmed the presence of an inflammatory myofibroblastic tumor. Conclusion. Inflammatory myofibroblastic tumors are uncommon neoplasms associated with a borderline risk of malignancy. Given that the symptoms can resemble those of common childhood respiratory conditions, it is crucial to consider this diagnosis in cases of persisting wheezing despite standard therapy. In such instances, performing a bronchoscopy is necessary for accurate diagnosis.